1.Curwen, M, Dunnel, K, Ashley, J. Hidden influenza deaths. Br Med J 1990; 300: 896.
2.Nicholson, KG. Influenza vaccination and the elderly. Br Med J 1990; 301: 617–8.
3.OPCS Monitor PP2 89/2. Office of Population Censuses and Surveys. London: HMSO.
4.Arden, NH, Patriarca, PA, Kendal, AP. Experiences in the use and efficacy of inactivated influenza vaccine in nursing homes. In: Kendall, AP.Patriarca, PA. eds. Options for the control of influenza. New York: AR Liss, 1986: 155–68.
5.Howells, Chl, Vesselinova-Jenkins, CK, Evans, AD, James, J. Influenza vaccination and mortality from bronchopneumonia in the elderly. Lancet 1975; 1: 381–3.
6.Serie, C, Barme, M, Hannoun, C, Thibon, M, Beck, H, Aquino, JP. Effects of vaccination on an influenza epidemic in a geriatric hospital. Dev Biol Stand 1977; 39: 317–21.
7.Patriarca, PA, Weber, JA, Parker, RA et al. , Efficacy of influenza vaccine in nursing homes. JAMA 1985; 253: 1136–9.
8.Gross, PA, Quinnan, GV, Rodstein, M et al. , Association of influenza immunization with reduction in mortality in an elderly population. Arch Intern Med 1988; 148: 562–5.
9.Immunisation against infectious disease. Joint Committee on Vaccination and Immunisation. Department of Health. 1990. London: HMSO.
10.Nicholson, KG, Wiselka, MJ, May, A. Influenza vaccination of the elderly: perceptions and policies of general practitioners and outcome of the 1985–86 immunization programme in Trent, UK. Vaccine 1987; 5: 302–6.
11.Kurinczuk, JJ, Nicholson, KG. Uptake of influenza vaccination by patients with serious cardiac disease. Br Med J 1989; 299: 367.
12.Pachuki, CT, Lentino, JR, Jackson, GG. Attitudes and behaviour of health care personnel regarding the use and efficacy of influenza vaccine. J Infect Dis 1985; 151: 1170–1.
13.Leicestershire final mid-year population estimates 1989: Population Estimates Unit; OPCS, London: HMSO.
14. Leicestershire Census of the Elderly, 1990 (Preliminary results). University of Leicester.
15.Nicholson, KG, Baker, DJ, Farquhar, A, Hurd, D, Kent, J, Smith, SH. Acute respiratory tract illness and influenza immunisation in homes for the elderly. Epidemiol Infect 1990; 105: 609–18.
16.Wingfield, WL, Pollack, D, Grunert, RR. Therapeutic efficacy of amantadine HCl and rimantadine HCl in naturally occurring influenza A2 respiratory illness in man. New Engl J Med 1969; 281: 579–84.
17.Little, JW, Hall, WJ, Douglas, RG, Mudholkar, GS, Speers, DM, Patel, K. Airway hyperreactivity and peripheral airway dysfunction in influenza A infection. Am Rev Resp Dis 1978; 118: 295–303.
18.Van Voris, LP, Betts, RF, Hayden, FG, Christmas, WA, Douglas, RG. Successful treatment of naturally occurring influenza A/USSR/77 H1N1. JAMA 1981; 245: 1128–31.
19.Hall, CB, Dolin, R, Gala, CL et al. , Children with influenza A infection: treatment with rimantadine. Pediatrics 1987; 80: 275–82.
20.Hayden, FG, Belshe, RB, Clover, RD, Hay, AJ, Oakes, MG, Soo, W. Emergence and apparent transmission of rimantadine-resistant influenza A virus in families. New Eng J Med 1989; 321: 1696–702.
21.Barker, WH, Mullooly, JP. Pneumonia and influenza deaths during epidemics; implications for treatment. Arch Intern Med 1982; 142: 85–9.
22.Zuckerman, M, Oxford, J, Wood, J, Taylor, J. Influenza A (H3N2) component of recommended vaccine induces antibody to current virus. Lancet 1990; 335: 179–80.
23.Nicholson, KG, Wiselka, MJ. Amantadine for influenza A – as well as, not instead of, immunisation in high risk groups. Br Med J 1991; 302: 425–6.